SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
progenics
An SI Board Since January 1998
Posts SubjectMarks Bans Symbol
139 21 0 PGNX
Emcee:  William Nelson Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
89Where was mstar getting a year away from submission? Did they mean approval? Evtuck-1/10/2008
88mstar: On Thursday, Progenics Pharmaceuticals PGNX announced a secondary offerimopgcw-9/22/2007
87Progenics Pharmaceuticals (PGNX ) sank after it and Wyeth (WYE) announced they widos-3/7/2007
86Seems like an oral version of MNTX may be on the way... Wyeth (WYE) and ProgeniIan@SI-8/22/2006
85Wyeth and Progenics Pharmaceuticals Announce Worldwide Collaboration to Develop nigel bates-12/27/2005
84Top line PIII results for MNTX: >>TARRYTOWN, N.Y.--(BUSINESS WIRE)--Marchtuck-3/10/2005
83>>TARRYTOWN, N.Y.--(BUSINESS WIRE)--Jan. 20, 2005-- Progenics Pharmaceutictuck-1/20/2005
82Progenics Achieves Enrollment Target in Pivotal Phase 3 Clinical Trial of MethylJim Oravetz-1/4/2005
81Progenics and Cytogen Announce Award of $7.4 Million in NIH Grants for Prostate Jim Oravetz-1/4/2005
80>>TARRYTOWN, N.Y.--(BUSINESS WIRE)--Oct. 7, 2004--Progenics Pharmaceuticaltuck-10/7/2004
79>>CHICAGO, Aug 10 (Reuters) - Shares of Progenics Pharmaceuticals Inc. (Natuck-8/10/2004
78>>BANGKOK, Thailand--(BUSINESS WIRE)--July 15, 2004--Progenics Pharmaceutituck-7/15/2004
77This looks very interesting, but in the clinic 2014? Didn't Danishefsky diskeokalani'nui-5/4/2004
76pro140, it's about time! >>"Whereas the small-molecule inhibitkeokalani'nui-5/4/2004
75[CD81 is an entry coreceptor for hepatitis C virus] >>Published online betuck-5/4/2004
74>>LONDON--(BUSINESS WIRE)--May 4, 2004--Progenics Pharmaceuticals, Inc. (Ntuck-5/4/2004
73Progenics Reports Methylnaltrexone Activity in Reversing Opioid-Induced Urinary keokalani'nui-10/10/2003
72PGNX has had an incredible run since the last post. Here's an update on thetuck-7/14/2003
71PGNX retesting the bottom these days. Wondering if the market is upset that MNTtuck-3/11/2003
70>>TARRYTOWN, N.Y.--(BUSINESS WIRE)--Dec. 20, 2002--Progenics Pharmaceuticatuck-12/20/2002
69sigh... Cytogen and Progenics Initiate Phase I Clinical Testing of New Therapeukeokalani'nui-12/19/2002
68Progenics Reports Progress in Developing a New Class of AIDS Vaccines Publicatikeokalani'nui-10/1/2002
67>>SAN DIEGO--(BUSINESS WIRE)--Sept. 27, 2002--Progenics Pharmaceuticals, Ituck-9/27/2002
66Progenics, which has been really brutalized in the absence of news lately, has atuck-9/23/2002
65PFE license IPs on CCR5 and HIV. Message 17520705 Nice eye, Rick.keokalani'nui-5/28/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News